Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases	autoimmune disease, immune system disorder	Not yet recruiting	Phase 1 / Phase 2	2025-09-08		NCT07161193

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hebei Senlang Biotechnology Inc., Ltd.	14
Henan Province Engineering Technology Research Center of Immunological Precision Medicine and Artificial Intelligence Application, Luoyang, China	1
The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine	5

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Henan Province Engineering Technology Research Center of Immunological Precision Medicine and Artificial Intelligence Application, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, China	Luoyang	China	1